2013
DOI: 10.1017/s0967199413000397
|View full text |Cite
|
Sign up to set email alerts
|

Immunization against recombinant GnRH-I alters testicular structure in an experimental boar model

Abstract: The aim of this study was to evaluate and to compare testicular tissue in immunized and control boars. Eighteen male piglets, aged 12 weeks, were vaccinated twice intramuscularly with a maltose-binding protein-gonadotropin-releasing hormone I hexamer peptide (MBP-GnRH-I6). Blood samples were taken at 12, 18, 21 and 24 weeks of age. Serum concentrations of testosterone and GnRH-I antibodies were determined by radioimmunoassay. The pigs were sacrificed 6 weeks after the second immunization. Testicular weight and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
2
0

Year Published

2018
2018
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 22 publications
1
2
0
Order By: Relevance
“…Interstitial endocrine cells were shrunken and had both a small nucleus and limited cytoplasmic area. Similar results have been reported by other studies (Einarsson et al 2011;Kubale et al 2013;Li et al 2015). These changes in the morphology of interstitial endocrine cells were consistent with a loss of function and the decrease in testosterone and androstenone (Kubale et al 2013).…”
Section: Discussionsupporting
confidence: 92%
See 2 more Smart Citations
“…Interstitial endocrine cells were shrunken and had both a small nucleus and limited cytoplasmic area. Similar results have been reported by other studies (Einarsson et al 2011;Kubale et al 2013;Li et al 2015). These changes in the morphology of interstitial endocrine cells were consistent with a loss of function and the decrease in testosterone and androstenone (Kubale et al 2013).…”
Section: Discussionsupporting
confidence: 92%
“…According to Original Paper Veterinarni Medicina, 63, 2018 (01): 18-27 doi: 10.17221/121/2017-VETMED the manufacturer's instructions, the vaccine's primary dose can be administered no earlier than at eight weeks. In fact, researchers have used various vaccination schedules, with the primer dose being administered at 11-16 weeks and the booster dose at 18-21 weeks (Einarsson et al 2009;Batorek et al 2012;Kubale et al 2013;Li et al 2015;Shi et al 2016;Needham et al 2017). In these cases, the eff ect of vaccination may persist for as long as 22 weeks (Zamaratskaia et al 2008;Einarsson et al 2009).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation